Serum amyloid A3 exacerbates cancer by enhancing the suppressive capacity of myeloid-derived suppressor cells via TLR2-dependent STAT3 activation (Q39012704)

From Wikidata

Jump to navigation Jump to search

scientific article published on 17 April 2014

Language	Label	Description	Also known as
English	Serum amyloid A3 exacerbates cancer by enhancing the suppressive capacity of myeloid-derived suppressor cells via TLR2-dependent STAT3 activation	scientific article published on 17 April 2014

Statements

scholarly article

1 reference

Europe PubMed Central

8 September 2017

Serum amyloid A3 exacerbates cancer by enhancing the suppressive capacity of myeloid-derived suppressor cells via TLR2-dependent STAT3 activation (English)

1 reference

Europe PubMed Central

8 September 2017

toll-like receptor

0 references

author name string

Jung-Mi Lee

1

1 reference

Europe PubMed Central

8 September 2017

Eun-Kyung Kim

2

1 reference

Europe PubMed Central

8 September 2017

Hyungseok Seo

3

1 reference

Europe PubMed Central

8 September 2017

Insu Jeon

4

1 reference

Europe PubMed Central

8 September 2017

Min-Ji Chae

5

1 reference

Europe PubMed Central

8 September 2017

Young-Jun Park

6

1 reference

Europe PubMed Central

8 September 2017

Boyeong Song

7

1 reference

Europe PubMed Central

8 September 2017

Yun-Sun Kim

8

1 reference

Europe PubMed Central

8 September 2017

Yeon-Jeong Kim

9

1 reference

Europe PubMed Central

8 September 2017

Hyun-Jeong Ko

10

1 reference

Europe PubMed Central

8 September 2017

Chang-Yuil Kang

11

1 reference

Europe PubMed Central

8 September 2017

language of work or name

0 references

publication date

17 April 2014

1 reference

Europe PubMed Central

8 September 2017

European Journal of Immunology

1 reference

Europe PubMed Central

8 September 2017

44

1 reference

Europe PubMed Central

8 September 2017

6

1 reference

Europe PubMed Central

8 September 2017

1672-1684

1 reference

Europe PubMed Central

8 September 2017

Cancer-related inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Molecular pathways and targets in cancer-related inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Mechanisms linking pathogens-associated inflammation and cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Myeloid-derived suppressor cells: linking inflammation and cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Serum amyloid A: an acute-phase protein involved in tumour pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Molecular interactions of acute phase serum amyloid A: possible involvement in carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Serum amyloid A, the major vertebrate acute-phase reactant

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Regulation of serum amyloid A protein expression during the acute-phase response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Amyloid precursors and amyloidosis in inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Significance of serum amyloid A on the prognosis in patients with renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Comparative time-dependent analysis of potential inflammation biomarkers in lymphoma-bearing SJL mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Identification of tumor-associated plasma biomarkers using proteomic techniques: from mouse to human

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Functional changes in myeloid-derived suppressor cells (MDSCs) during tumor growth: FKBP51 contributes to the regulation of the immunosuppressive function of MDSCs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Myeloid-derived suppressor cells as regulators of the immune system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Interleukin-6 induces Gr-1+CD11b+ myeloid cells to suppress CD8+ T cell-mediated liver injury in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Modulation of the antitumor immune response by complement

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Adhesion of human platelets to serum amyloid A

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Enhanced efficacy of DNA vaccination against Her-2/neu tumor antigen by genetic adjuvants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

21 January 2018

Inflammation and necrosis promote tumour growth

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum amyloid A protein (SAA) in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343867

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJI.201343867

1 reference

Europe PubMed Central

8 September 2017

1 reference

Europe PubMed Central

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39012704&oldid=1802372974"